Diabetes mellitus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Surgery has major effects on carbohydrate metabolism and thus presents special risks for patients with diabetes. Surgical mortality rates for patients with diabetes have declined but the successful perioperative care of these patients requires close cooperation between surgeons, anesthesiologists, and primary physicians to prevent complications. There are 25.8 million children and adults in the USA with diabetes – 8.3% of the population [1]. Diabetes is listed as a diagnosis on 23% of hospital discharges [2]. At least half of these patients will require surgery at some point in their lives. In addition to surgical conditions typical of the general population, patients with diabetes have an increased incidence of occlusive vascular disease; cholelithiasis; ophthalmic disease (i.e., cataract extraction, vitrectomy); renal disease; and infection. Three of four patients with diabetes are older than 40 years and are approaching a time of life when surgical indications increase. The presence of diabetes typically is known prior to surgery, although a new diagnosis of diabetes is made in the perioperative period in as many as 12% of cases [3]. Hyperglycemia in the hospital is common and may result from stress, infection, effect of procedures, or is iatrogenic [4]. Previously, glucose levels between 100 and 200 mg/dL were not treated in the perioperative period. This practice was challenged by studies suggesting that more aggressive treatment of elevated glucose levels with insulin reduces infectious complications, decreases mortality, and decreases length of hospital stay [5–7]. Many hospitals developed programs, and started treating both medical and surgical patients with intensive insulin therapy to maintain blood glucose at or below 110 mg/dL, particularly in ICU settings. But, following studies performed in other ICUs, particularly medical ones, failed to reproduce the beneficial effects of intensive insulin therapy. In fact, intensive insulin therapy increased the risk of death [8–11]. One study demonstrated a 2.6% absolute increase in 90-day mortality in patients randomized to tight glucose control [10]. This may have been related to the increased risk for hypoglycemia in the intensive insulin group [12].

Original languageEnglish (US)
Title of host publicationMedical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition
PublisherCambridge University Press
Pages343-349
Number of pages7
ISBN (Print)9780511920660, 9781107009165
DOIs
StatePublished - Jan 1 2010

Fingerprint

Diabetes Mellitus
Insulin
Perioperative Period
Glucose
Mortality
Length of Stay
Perioperative Care
Cholelithiasis
Cataract Extraction
Eye Diseases
Vitrectomy
Carbohydrate Metabolism
Therapeutics
Infection
Vascular Diseases
Hypoglycemia
Hyperglycemia
Population
Blood Glucose
Physicians

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prescott, P. T. (2010). Diabetes mellitus. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition (pp. 343-349). Cambridge University Press. https://doi.org/10.1017/CBO9780511920660.032

Diabetes mellitus. / Prescott, Pamela T.

Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. p. 343-349.

Research output: Chapter in Book/Report/Conference proceedingChapter

Prescott, PT 2010, Diabetes mellitus. in Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, pp. 343-349. https://doi.org/10.1017/CBO9780511920660.032
Prescott PT. Diabetes mellitus. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press. 2010. p. 343-349 https://doi.org/10.1017/CBO9780511920660.032
Prescott, Pamela T. / Diabetes mellitus. Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. pp. 343-349
@inbook{754cecd8d0cc41d9899ab6ede657ba5c,
title = "Diabetes mellitus",
abstract = "Surgery has major effects on carbohydrate metabolism and thus presents special risks for patients with diabetes. Surgical mortality rates for patients with diabetes have declined but the successful perioperative care of these patients requires close cooperation between surgeons, anesthesiologists, and primary physicians to prevent complications. There are 25.8 million children and adults in the USA with diabetes – 8.3{\%} of the population [1]. Diabetes is listed as a diagnosis on 23{\%} of hospital discharges [2]. At least half of these patients will require surgery at some point in their lives. In addition to surgical conditions typical of the general population, patients with diabetes have an increased incidence of occlusive vascular disease; cholelithiasis; ophthalmic disease (i.e., cataract extraction, vitrectomy); renal disease; and infection. Three of four patients with diabetes are older than 40 years and are approaching a time of life when surgical indications increase. The presence of diabetes typically is known prior to surgery, although a new diagnosis of diabetes is made in the perioperative period in as many as 12{\%} of cases [3]. Hyperglycemia in the hospital is common and may result from stress, infection, effect of procedures, or is iatrogenic [4]. Previously, glucose levels between 100 and 200 mg/dL were not treated in the perioperative period. This practice was challenged by studies suggesting that more aggressive treatment of elevated glucose levels with insulin reduces infectious complications, decreases mortality, and decreases length of hospital stay [5–7]. Many hospitals developed programs, and started treating both medical and surgical patients with intensive insulin therapy to maintain blood glucose at or below 110 mg/dL, particularly in ICU settings. But, following studies performed in other ICUs, particularly medical ones, failed to reproduce the beneficial effects of intensive insulin therapy. In fact, intensive insulin therapy increased the risk of death [8–11]. One study demonstrated a 2.6{\%} absolute increase in 90-day mortality in patients randomized to tight glucose control [10]. This may have been related to the increased risk for hypoglycemia in the intensive insulin group [12].",
author = "Prescott, {Pamela T}",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511920660.032",
language = "English (US)",
isbn = "9780511920660",
pages = "343--349",
booktitle = "Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Diabetes mellitus

AU - Prescott, Pamela T

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Surgery has major effects on carbohydrate metabolism and thus presents special risks for patients with diabetes. Surgical mortality rates for patients with diabetes have declined but the successful perioperative care of these patients requires close cooperation between surgeons, anesthesiologists, and primary physicians to prevent complications. There are 25.8 million children and adults in the USA with diabetes – 8.3% of the population [1]. Diabetes is listed as a diagnosis on 23% of hospital discharges [2]. At least half of these patients will require surgery at some point in their lives. In addition to surgical conditions typical of the general population, patients with diabetes have an increased incidence of occlusive vascular disease; cholelithiasis; ophthalmic disease (i.e., cataract extraction, vitrectomy); renal disease; and infection. Three of four patients with diabetes are older than 40 years and are approaching a time of life when surgical indications increase. The presence of diabetes typically is known prior to surgery, although a new diagnosis of diabetes is made in the perioperative period in as many as 12% of cases [3]. Hyperglycemia in the hospital is common and may result from stress, infection, effect of procedures, or is iatrogenic [4]. Previously, glucose levels between 100 and 200 mg/dL were not treated in the perioperative period. This practice was challenged by studies suggesting that more aggressive treatment of elevated glucose levels with insulin reduces infectious complications, decreases mortality, and decreases length of hospital stay [5–7]. Many hospitals developed programs, and started treating both medical and surgical patients with intensive insulin therapy to maintain blood glucose at or below 110 mg/dL, particularly in ICU settings. But, following studies performed in other ICUs, particularly medical ones, failed to reproduce the beneficial effects of intensive insulin therapy. In fact, intensive insulin therapy increased the risk of death [8–11]. One study demonstrated a 2.6% absolute increase in 90-day mortality in patients randomized to tight glucose control [10]. This may have been related to the increased risk for hypoglycemia in the intensive insulin group [12].

AB - Surgery has major effects on carbohydrate metabolism and thus presents special risks for patients with diabetes. Surgical mortality rates for patients with diabetes have declined but the successful perioperative care of these patients requires close cooperation between surgeons, anesthesiologists, and primary physicians to prevent complications. There are 25.8 million children and adults in the USA with diabetes – 8.3% of the population [1]. Diabetes is listed as a diagnosis on 23% of hospital discharges [2]. At least half of these patients will require surgery at some point in their lives. In addition to surgical conditions typical of the general population, patients with diabetes have an increased incidence of occlusive vascular disease; cholelithiasis; ophthalmic disease (i.e., cataract extraction, vitrectomy); renal disease; and infection. Three of four patients with diabetes are older than 40 years and are approaching a time of life when surgical indications increase. The presence of diabetes typically is known prior to surgery, although a new diagnosis of diabetes is made in the perioperative period in as many as 12% of cases [3]. Hyperglycemia in the hospital is common and may result from stress, infection, effect of procedures, or is iatrogenic [4]. Previously, glucose levels between 100 and 200 mg/dL were not treated in the perioperative period. This practice was challenged by studies suggesting that more aggressive treatment of elevated glucose levels with insulin reduces infectious complications, decreases mortality, and decreases length of hospital stay [5–7]. Many hospitals developed programs, and started treating both medical and surgical patients with intensive insulin therapy to maintain blood glucose at or below 110 mg/dL, particularly in ICU settings. But, following studies performed in other ICUs, particularly medical ones, failed to reproduce the beneficial effects of intensive insulin therapy. In fact, intensive insulin therapy increased the risk of death [8–11]. One study demonstrated a 2.6% absolute increase in 90-day mortality in patients randomized to tight glucose control [10]. This may have been related to the increased risk for hypoglycemia in the intensive insulin group [12].

UR - http://www.scopus.com/inward/record.url?scp=84923409703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923409703&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511920660.032

DO - 10.1017/CBO9780511920660.032

M3 - Chapter

AN - SCOPUS:84923409703

SN - 9780511920660

SN - 9781107009165

SP - 343

EP - 349

BT - Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition

PB - Cambridge University Press

ER -